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Effects of high-flux hemodialysis on oxidant stress. patients. Increased plasma protein oxidation is evidenced
Background. Neutrophil oxygen radical production is in- by changes in the concentration of free sulfhydryl groups,
creased in end-stage renal disease (ESRD) patients and it is carbonyl groups, and 3-chlorotyrosine on plasma proteins
further enhanced during dialysis with low-flux cellulosic mem-
[5–8], and the appearance of advanced oxidation proteinbranes. This increased oxygen radical production may contrib-
products (AOPP) [9]. Studies of lipid peroxidation haveute to the protein and lipid oxidation observed in ESRD pa-
produced ambiguous results, with levels of lipid peroxi-tients. We tested the hypothesis that high-flux hemodialysis
does not increase oxygen radical production and that it is not dation products being reported as normal [10, 11] or in-
associated with protein oxidation. creased [12, 13]. Similarly, in vitro measurements of the lag
Methods. Neutrophil oxygen radical production was mea- time for copper-induced low-density lipoprotein (LDL)
sured during dialysis with high-flux dialyzers containing poly-
oxidation have yielded values less than [3] and not differ-sulfone and cellulose triacetate membranes. Free sulfhydryl
ent from [14, 15] normal. The discrepancies between theseand carbonyl groups and advanced oxidation protein products
studies may reflect the short plasma half-lives of lipidwere measured to assess plasma protein oxidation.
Results. Pre-dialysis, neutrophil oxygen radical production peroxidation products and the relative non-specificity of
was significantly greater than normal and increased significantly the tests [16]. More recently, a sensitive and specific gas
as blood passed through the dialyzer in the first 30 minutes of chromatography-mass spectrometry assay was used to mea-
dialysis. Post-dialysis, however, neutrophil oxygen radical pro-
sure plasma concentrations of esterified F2-isoprostanes,duction had decreased and was not different from normal. Pre-
which are chemically stable products of arachidonic aciddialysis, significant plasma protein oxidation was evident from
oxidation [17]. This study found significantly higher lev-reduced free sulfhydryl groups, increased carbonyl groups, and
increased advanced oxidation protein products. Post-dialysis, els of esterified F2-isoprostanes in hemodialysis patients
plasma protein free sulfhydryl groups had increased to normal than in normal subjects. Taken together, these studies sup-
levels, while plasma protein carbonyl groups increased slightly, port the hypothesis that end-stage renal disease (ESRD)
and advanced oxidation protein products remained unchanged. is associated with both protein and lipid oxidation.Conclusions. The results of this study show that neutrophil
We have demonstrated that neutrophils of hemodialy-oxygen radical production normalizes during high-flux dialysis,
sis patients are primed for an enhanced respiratory burstdespite a transient increase early in dialysis. This decrease in
oxygen radical production is associated with an improvement following stimulation with Staphylococcus aureus [18].
in some, but not all, measures of protein oxidation. This increase in respiratory burst activity may contribute
to protein and lipid oxidation in hemodialysis patients.
The protein and lipid oxidation might be exacerbated if
Oxygen radicals are implicated as mediators of renal the dialyzer membrane acted as a further stimulus to oxy-
injury in diverse experimental models of renal disease [1] gen radical production. We have previously shown that
and of accelerated atherosclerosis in hemodialysis patients exposure to low-flux cellulosic dialysis membranes is suf-
ficient to both further prime and stimulate oxygen radicalthrough the oxidation of low-density lipoproteins [2, 3].
release by neutrophils [19]. However, there is little infor-It has also been suggested that oxidant exposure may con-
mation on the impact of other membranes on oxygentribute to the high rate of cardiovascular disease in these
radical production. The purpose of this study was to de-patients [4]. A number of studies have demonstrated
termine the impact of hemodialysis with high-flux poly-oxidation of both proteins and lipids in hemodialysis
sulfone and cellulose triacetate membranes on neutro-
phil respiratory burst activity and protein oxidation.
Key words: High-flux hemodialysis, neutrophil, oxygen radicals, oxi-
dant stress, protein oxidation.
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were a stable hemodialysis prescription, a well-function- prime was not discarded at the initiation of dialysis. In-
stead, the blood circuit was completed, the blood flowing native fistula or Gore-Tex graft (W.L. Gore, Flag-
staff, AZ, USA), and an absence of clinical evidence of rate immediately set to 300 mL/min, and zero time taken
as the moment when blood first entered the dialyzer. Neu-infection during the month prior to the study. One pa-
tient received a renal transplant before completing the trophil counts and respiratory burst activity were deter-
mined in all samples. Markers of protein oxidation wereprotocol; the data from this patient were omitted from
this report. The average age of the remaining 11 patients determined in pre- and post-dialysis samples.
was 51  5 years and their average time on dialysis was
Neutrophil count49  11 months. The cause of ESRD was diabetes in
five patients, glomerulonephritis in three patients, hyper- Blood for white cell count and differential was col-
lected in ethylenediaminetetraacetic acid (EDTA) andtension in two patients, and was unknown in one patient.
Blood samples for determining normal values of neu- analyzed by routine clinical laboratory methods.
trophil respiratory burst activity and markers of protein
Neutrophil respiratory burst activityoxidation were obtained from healthy volunteers, both
men and women, who ranged in age from 23 to 54 years. Blood for determination of resting and stimulated re-
spiratory burst activity was collected in acid citrate dex-At the time blood samples were obtained, all control sub-
jects had been free of infection for at least 2 weeks and trose (ACD) (National Institutes of Health formula A).
Respiratory burst activity was determined by the mea-were taking no medications, including no anti-inflamma-
tory drugs in the previous 48 hours. surement of H2O2 production using a flow cytometric
method as previously described [20]. Samples were ana-The Human Studies Committee of the University of
Louisville approved the study and informed consent was lyzed for phagocytosis and stimulated H2O2 production
by flow cytometry (Epics Profile II, Coulter, Hialeah,obtained from each subject before each was enrolled in
the study. FL, USA). Data are presented as the mean channel of
fluorescence intensity. The flow cytometer was calibrated
Study design before the analysis of each set of samples with Standard-
Brite beads (Coulter).Each patient underwent a single treatment with a dia-
lyzer containing polysulfone membrane (F80A, Fresen-
Markers of plasma protein oxidationius USA, Lexington, MA, USA) and a single treatment
with a dialyzer containing cellulose triacetate membrane Blood for determination of markers of plasma protein
oxidation was collected in EDTA. The plasma was sepa-(CT190G, Baxter Healthcare Corp., Deerfield, IL, USA).
The two dialyzers were used in random order and a new rated immediately by centrifugation and stored at 70C
until analysis. Measurements of free sulfhydryl groupsdialyzer was used for each treatment. All treatments
were performed using a volume control dialysate deliv- and carbonyl groups on plasma protein and AOPP were
used to assess the extent of plasma protein oxidation.ery system (Model 550, Baxter Healthcare Corp.).
All treatments were performed according to the pa- Plasma protein free sulfhydryl groups were determined
by the method of Ellman, as described by Sedlak andtients’ routine prescriptions, except that the blood flow
rate was set at 300 mL/min. The treatment time was 3.7 Lindsay [21], and as modified by Hu et al [22]. Briefly,
50 L of plasma was added to disposable cuvettes con-0.2 hours and the dialysate flow rate was 700 mL/min.
Anticoagulation was achieved by a loading dose (2523 taining 1 mL 0.1 mol/L Tris (pH 8.2) containing 10
mmol/L EDTA and 50 L of 10 mmol/L 5,5-dithiobis-296 IU) and constant infusion (1818  155 IU/hour) of
heparin. The patients’ pre-dialysis weight was 81.1  5.2 2-nitrobenzoic acid (DTNB) in methanol. A blank, pre-
pared in the same way but without DTNB, was run withkg and fluid removal during dialysis was 3.4  0.2 kg.
None of these treatment parameters differed signifi- each sample and all samples were assayed in triplicate.
Following incubation for 15 minutes at room tempera-cantly between the two dialyzers.
Neutrophil respiratory burst activity and markers of ture, the absorbance was read at 412 nm on a spectropho-
tometer. After subtraction of reagent and sample blanks,protein oxidation were determined before, during, and
after dialysis with each dialyzer. A pre-dialysis blood the concentration of free sulfhydryl groups was determined
using the 2-nitro-5-thiobenzoic acid (TNB) extinction co-sample was obtained immediately following insertion of
the access needles and withdrawal of 3 mL blood to clear efficient of 14,100 M1 cm1 [23]. Plasma protein carbonyl
groups were determined by the method of Buss et alany plasma or tissue components activated during needle
insertion. Subsequent blood samples were obtained from [24] as modified by Winterbourn and Buss [25], using a
commercially available enzyme-linked immunosorbentthe arterial and venous lines of the dialyzer after 1, 3,
5, 15, and 30 minutes of dialysis. A post-dialysis sample assay (ELISA) kit (Zentech Protein Carbonyl Kit, Ze-
nith Technology Corp., Dunedin, New Zealand). Allwas obtained from the arterial line at the end of dialysis.
To standardize the timing of sample collection, the saline samples were assayed in triplicate. AOPP were deter-
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Table 1. Neutrophil counts during high-flux hemodialysis
Neutrophil count 103/lL








Data are presented as meanSEM for N  11 for each dialyzer. Neutrophil
counts were corrected for hemoconcentration using concurrent hematocrit val-
ues. Results of the statistical analysis are presented in the text.
mined using the method of Witko-Sarsat et al [9]. Briefly,
samples were diluted 1:5 in buffer and 200 L added to
the wells of a microtiter plate. Acetic acid (20 L) was
added to each well and the plate incubated at room
temperature for 2 minutes on an agitator. The ab-
sorbance was then read at 340 nm using a microplate
reader. AOPP concentrations were calculated in terms
of chloramine-T equivalents using a calibration curve
constructed from standards prepared by the addition of
10 L 1.16 mol/L potassium iodide to varying concentra-
tions of chloromine-T. Plasma protein concentrations
were measured by the biuret method (Sigma Chemical
Co., St. Louis, MO, USA).
Fig. 1. Resting neutrophil respiratory burst activity during hemodialy-
Data analysis sis with F80A and CT190G dialyzers. Data are presented as mean 
SEM for N  11. Measurements made at the inlet to the dialyzer areNeutrophil counts were corrected for hemoconcentra-
indicated by () and measurements made at the outlet to the dialyzer
tion arising from ultrafiltration using concurrent hemato- are indicated by (). *, Significantly different from other time points
(P  0.001); †, Significantly different from arterial (P  0.001). Thecrit values. The effects of dialyzer type and time on each
shaded area represents the range for normal subjects (mean  2 SD,parameter were assessed by a two-way analysis of vari-
N  18).
ance for repeated measures. Values obtained at the out-
let of the dialyzer were compared to those obtained at
the inlet using Student t test for paired data. A P value
less than 0.05 was considered significant. Data are pre- respectively). Resting and S. aureus-stimulated H2O2
production was significantly increased above normal atsented as mean  SEM.
the beginning of dialysis (Figs. 1 and 2). There was no
change in respiratory burst activity in neutrophils enter-
RESULTS
ing the dialyzer during the first 30 minutes of dialysis;
Neutrophil count however, by the end of dialysis both resting and stimu-
lated H2O2 production had decreased significantly (P Changes in neutrophil count with time are presented
in Table 1. The neutrophil count decreased significantly 0.001) to values within the normal range. The change in
stimulated H2O2 production was not due to a change induring the first 15 minutes of dialysis (P  0.001), both
in terms of the actual cell count and following correction the level of phagocytosis, which did not change from
pre- to post-dialysis (data not shown). While respiratoryfor hemoconcentration. By 30 minutes the neutrophil
count was not different from the pre-dialysis value. burst activity decreased from pre- to post-dialysis, pas-
sage of blood through the dialyzer was associated withChanges in neutrophil count did not differ between the
two dialyzers (P  0.174). a significant increase in resting and stimulated H2O2 pro-
duction after 15 minutes of dialysis.
Neutrophil respiratory burst activity
Plasma protein oxidationThere was no difference between the two dialyzers in
their effect on respiratory burst activity (P  0.270 and Concentrations of markers of protein oxidation are
presented in Table 2. There was no difference betweenP  0.170 for resting and stimulated H2O2 production,
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(P  0.001). Dialysis had no effect on the concentration
of AOPP (P  0.321) and concentrations of AOPP re-
mained significantly greater than normal post-dialysis
(P  0.001).
DISCUSSION
The results of this study demonstrate that hemodialy-
sis patients are in a state of oxidant stress. Pre-dialysis,
resting and stimulated neutrophil oxygen radical produc-
tion is significantly increased above normal and there
is significant protein oxidation, as demonstrated by a
reduction in plasma protein free sulfhydryl groups and
increases in plasma protein carbonyl groups and ad-
vanced oxidation protein products.
Dialysis with high-flux membranes fabricated from ei-
ther polysulfone or cellulose triacetate transiently acti-
vated neutrophils early in the course of hemodialysis, as
evidenced by neutropenia and an increase in respiratory
burst activity as blood transited the dialyzer. The comple-
ment fragment, C5a, has been reported to stimulate [26]
and, at substimulatory concentrations, to prime [27] re-
spiratory burst activity in neutrophils. Thus, the transient
activation of neutrophils observed after 15 minutes of
dialysis may have resulted from the modest level of com-
plement activation that is known to occur with both
cellulose triacetate and polysulfone membranes [28, 29].Fig. 2. Staphylococcus aureus–stimulated neutrophil respiratory burst
activity during hemodialysis with F80A and CT190G dialyzers. Data However, over the full course of the dialysis treatment,
are presented as mean  SEM for N  11. Measurements made at the both membranes were associated with a normalization ofinlet to the dialyzer are indicated by () and measurements made at
the level of respiratory burst activity. We have previouslythe outlet to the dialyzer are indicated by (). *, Significantly different
from other time points (P  0.002); †, Significantly different from shown that plasma from hemodialysis patients contains
arterial (P  0.05). The shaded area represents the range for normal an unknown factor or factors capable of priming respira-subjects (mean  2 SD, N  18).
tory burst activity in normal neutrophils [18]. Other in-
vestigators, working with serum from hemodialysis pa-
tients [30] or peritoneal dialysis effluent [31, 32], have
dialyzers in the concentrations of markers of protein oxi- also shown the presence of a priming factor or factors
dation pre- and post-dialysis (P 0.698 for plasma protein with a molecular size less than 1.0 to 1.2 kD. The results
free sulfhydryl groups, P  0.963 for protein carbonyls, of the present study are consistent with removal of this
and P 0.715 for AOPP). Pre-dialysis, the concentration low-molecular-weight factor or factors, leading to a re-
of plasma protein free sulfhydryl groups was significantly duction in neutrophil priming.
less than normal (P  0.001), while concentrations of The decrease in respiratory burst activity from pre- to
plasma protein carbonyl groups (P  0.007) and AOPP post-dialysis was accompanied by changes in the markers
(P  0.001) were significantly greater than normal. Dial- of plasma protein oxidation. Plasma protein free sulfhy-
ysis was associated with an increase in the concentration dryl groups increased to normal, suggesting a reduction
of plasma protein free sulfhydryl groups (P  0.001), in oxidant stress. In contrast, protein carbonyl groups in-
and post-dialysis the concentration did not differ from creased slightly in concentration, indicating a worsening
normal (P  0.817). Similar results were obtained when oxidant damage. These apparently contradictory findings
plasma protein free sulfhydryl groups were expressed as may be reconciled by considering the reactions involved
nanomole per milligram of protein, calculated using total in sulfhydryl group oxidation and carbonyl formation.
plasma protein concentrations (data not shown). In con- Protein sulfhydryl groups can be oxidized through the
trast to the normalization in concentration observed for formation of a disulfide bond with low-molecular-weight
plasma protein free sulfhydryl groups, the concentration aminothiols, such as cysteine and homocysteine, present
of plasma protein carbonyl groups increased slightly, but in plasma. This oxidation reaction is reversible. Cysteine
significantly (P  0.029) over the course of dialysis and is the most abundant aminothiol in plasma. Protein-bound
cysteine concentrations are significantly increased in he-remained significantly greater than normal post-dialysis
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Table 2. Concentrations of plasma protein oxidation markers in hemodialysis patients and normal subjects and the effect of high-flux hemodialysis
Normal (N  12 to 17) F80A (N  11) CT190G (N  11)
Free sulfhydryl groups lmol/L
Pre-dialysis 43816 26822a 26519a
Post-dialysis 42515b 40823b
Carbonyl groups nmol/mg
Pre-dialysis 0.0410.008 0.1440.037a 0.1450.030a
Post-dialysis 0.1750.029ab 0.1780.035ab
AOPP lmol/L
Pre-dialysis 748 19130a 19127a
Post-dialysis 19037a 16326a
Data are presented as meanSEM. a Different from normal; b Different from pre-dialysis
modialysis patients [33, 34] and decrease significantly concentrations are reported to be decreased [43], whereas
erythrocyte total glutathione levels are reported to befrom pre- to post-dialysis [34]. Similar findings have been
reported for the less abundant aminothiol, homocysteine normal [44]. However, superoxide dismutase, catalase,
and the glutathione system are primarily intracellular[33, 34]. In addition to aminothiols, protein sulfhydryl
groups can be oxidized by reversible reactions with cya- antioxidants (for example, the plasma concentration of
glutathione is only 2 mol/L [45]) and they are unlikelynate (CNO) [35], which spontaneously forms from urea
under physiological conditions [36], and methylglyoxal to play a significant role in protecting against oxidation
of plasma proteins. Important antioxidants in plasma[37], which is present in increased concentrations in dial-
ysis patients [38]. Thus, removal by dialysis of free include vitamins C and E, uric acid, and albumin [46].
Vitamin C levels have been reported to be low in some,aminothiols, or other substances capable of binding re-
versibly to protein sulfhydryl groups, could lead to disso- but not all, hemodialysis patients [7, 47, 48]. We did not
measure vitamin C levels in this study; however, five ofciation of their bound component from plasma proteins
and restoration of the proteins’ free sulfhydryl groups. the patients were taking a supplement containing vitamin
C and it is unlikely that their vitamin C levels wereIn contrast to the reversible nature of protein sulfhy-
dryl group oxidation, the formation of protein carbonyl markedly low. Vitamin E levels are reported to be normal
in hemodialysis patients [7, 47]. Most free sulfhydrylgroups is irreversible [39]. Thus, the increased release
of oxygen radicals early in dialysis could lead to an irre- groups in plasma are found on albumin [49] and a recent
report by Himmelfarb and McMonagle showed that al-versible increase in protein carbonyl groups that was still
evident, post-dialysis, despite an overall reduction in oxi- bumin is also a major target for protein carbonyl forma-
tion in plasma [50]. Taken together, these findings sug-dant stress. High-flux dialysis had no effect on AOPP,
suggesting that these substances are relatively large and gest that albumin may be an important defense against
oxidant stress in hemodialysis patients. Such a role forthat they also represent a state of irreversible oxidation.
This conclusion is consistent with the studies of Witko- albumin is supported by the finding of Soejima et al that
patients with hypoalbuminemia demonstrate a greaterSarsat et al [9], who found AOPP to result from irrevers-
ible oxidant-induced protein cross-linking and to be clus- degree of erythrocyte membrane lipid peroxidation than
do patients with normal serum albumin concentrationstered at molecular weights of 70 kD and 670 kD. The
exact nature of AOPP remains to be defined, however, [51]. It is intriguing to consider that a reduction in antioxi-
dant capacity secondary to hypoalbuminemia might beand if they have significance beyond providing a global
measure of protein oxidation has yet to be determined. one factor in the increased mortality associated with
hypoalbuminemia in hemodialysis patients [52].Protein oxidation may be a consequence of increased
oxygen radical production, a deficiency in antioxidant We [20], and others [30, 53], have shown previously
that neutrophil oxygen radical production is increasedsystems, or both. Several studies, including the present
one, have shown that oxygen radical production is in- in patients with renal insufficiency prior to the initiation
of dialysis therapy. Such patients also exhibit evidence ofcreased in hemodialysis patients [18, 19, 30, 40, 41]. Super-
oxide dismutase, catalase, and the glutathione system plasma protein oxidation [6] and have elevated levels of
AOPP [54]. Taken together, these observations suggestprovide major protection against damage by oxygen radi-
cals. Studies of these enzymes in hemodialysis patients that uremia leads to a state of oxidant stress mediated
by increased oxygen radical production. The results ofhave yielded conflicting results. In erythrocytes, superoxide
dismutase activity is reported to be normal or decreased our present study suggest that high-flux hemodialysis
partially ameliorates this oxidant stress by removing sol-[7, 42, 43], glutathione peroxidase activity to be normal
[7, 42, 43], and glutathione reductase activity to be nor- utes responsible for increasing neutrophil oxygen radical
production and the low-molecular-weight aminothiolsmal or decreased [7, 43]. Whole blood total glutathione
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in uremic patients: An additional mechanism for accelerated ath-involved in oxidation of protein sulfhydryl groups. From
erosclerosis? Kidney Int 45:876–883, 1994
this perspective, high-flux hemodialysis could be consid- 4. Becker BN, Himmelfarb J, Henrich WL, Hakim RM: Reassessing
the cardiac risk profile in chronic hemodialysis patients: A hypothe-ered protective against the oxidant stress of uremia rather
sis on the role of oxidant stress and other non-traditional cardiacthan adding to oxidant stress as is often suggested.
risk factors. J Am Soc Nephrol 8:475–486, 1997
The present study provides no information on whether 5. Odetti P, Garibaldi S, Gurreri G, et al: Protein oxidation in
hemodialysis and kidney transplantation. Metabolism 45:1319–1322,low-flux hemodialysis also reduces oxidant stress. We
1996reported previously that dialysis with low-flux cellulose
6. Himmelfarb J, McMonagle E, McMenamin E: Plasma protein
membranes was associated with a reduction in neutrophil thiol oxidation and carbonyl formation in chronic renal failure.
Kidney Int 58:2571–2578, 2000oxygen radical production from pre- to post-dialysis, al-
7. Nguyen-Khoa T, Massy ZA, De Bandt JP, et al: Oxidative stressbeit at a non-significant level [55]. Moreover, Himmel-
and haemodialysis: Role of inflammation and duration of dialysis
farb, McMonagle, and McMenamin observed comparable treatment. Nephrol Dial Transplant 16:335–340, 2001
8. Himmelfarb J, McMenamin ME, Loseto G, Heinecke JW: Myelo-increases in the concentration of protein free sulfhydryl
peroxidase-catalyzed 3-chlorotyrosine formation in dialysis pa-groups from pre- to post-dialysis in patients treated with
tients. Free Radical Biol Med 31:1163–1169, 2001
high-flux polysulfone membranes and low-flux cellulose 9. Witko-Sarsat V, Friedlander M, Capeille`re-Blandin C, et al:
Advanced oxidation protein products as a novel marker of oxida-membranes [6]. These observations are consistent with
tive stress in uremia. Kidney Int 49:1304–1313, 1996the view that oxidant stress involves a relatively low-
10. Delmas-Beauvieux M-C, Combe C, Peuchant E, et al: Evaluation
molecular-weight agent (s) that is retained in uremia. of red blood cell lipoperoxidation in hemodialysed patients during
erythropoietin therapy supplemented or not with iron. NephronFurther studies comparing low-flux and high-flux hemo-
69:404–410, 1995dialysis and hemodiafiltration, which provides enhanced
11. Banni S, Lucchi L, Baraldi A, et al: No direct evidence of in-
removal of higher-molecular-weight solutes, may be use- creased lipid peroxidation in hemodialysis patients. Nephron 72:177–
183, 1996ful in more clearly defining the molecular weight of this
12. Loughrey CM, Young IS, Lightbody JH, et al: Oxidative stressretained solute (s). With dialysis three times a week, the
in haemodialysis. Q J Med 87:679–683, 1994
amelioration of oxidant stress appears to be transient, 13. Ko¨se K, Dog˘an P, Gu¨ndu¨z Z, et al: Oxidative stress in hemodia-
lyzed patients and the long-term effects of dialyzer reuse practice.since pre-dialysis neutrophil oxygen radical production
Clin Biochem 30:601–606, 1997and protein oxidation did not differ between the two 14. Sutherland WHF, Walker RJ, Ball MJ, et al: Oxidation of
dialyzers. Therefore, determining those dialysis strate- low density lipoproteins from patients with renal failure or renal
transplants. Kidney Int 48:227–236, 1995gies that best reduce this consequence of chronic uremia
15. Schulz T, Schiffl H, Scheithe R, et al: Preserved antioxidativewill also require studies of the time course of oxidant defense of lipoproteins in renal failure and during hemodialysis.
stress in hemodialysis patients. Friedman et al recently Am J Kidney Dis 25:564–571, 1995
16. Meagher EA, FitzGerald GA: Indices of lipid peroxidation inreported that plasma levels of the aminothiol, homocys-
vivo: Strengths and limitations. Free Radical Biol Med 28:1745–teine, are significantly lower in patients treated with noc- 1750, 2000
turnal hemodialysis six or seven nights per week com- 17. Handelman GJ, Walter MF, Adhikarla R, et al: Elevated plasma
F2-isoprostanes in patients on long-term hemodialysis. Kidney Intpared to those in patients treated with standard three
59:1960–1966, 2001times a week dialysis [56], suggesting that frequency of 18. Klein JB, McLeish KR, Ward RA: Transplantation, not dialysis,
treatment will be an important factor in reducing oxidant corrects azotemia-dependent priming of the neutrophil oxidative
burst. Am J Kidney Dis 33:483–491, 1999stress in hemodialysis patients.
19. Ward RA, McLeish KR: Hemodialysis with cellulose membranes
primes the neutrophil oxidative burst. Artif Organs 19:801–807,
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